COMPASS Pathways is rated Buy due to its strong Phase 3 trial results for COMP360, a synthetic psilocybin drug targeting treatment-resistant depression (TRD). The trials align with FDA guidance and show efficacy comparable to Spravato, positioning COMP360 for a potential fast-track FDA decision this quarter. The company holds $433.3 million in cash, supporting operations through 2028. Key risks include possible FDA advisory panel scrutiny and regulatory delays, especially if the New Drug Application (NDA) review extends beyond Q4 or if DEA rescheduling is delayed.
COMPASS Pathways provides context for readers interested in health-sector stocks. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 21, 2026 20:51 WIB: out of 150 priced US health stocks, 100 rose and 46 fell. Notable movers include GH at USD 169.34 with a 4.15% increase and 100% buy orders, CRL at USD 328.33 with a 4.08% increase, and MRVI at USD 7.49 with a 4.03% increase. Typical hold times range from 3 to 34 days on Pluang.
The BBB National Programs’ National Advertising Division reviewed Royal Caribbean Group's advertising related to gratuities and found the company's recent modifications to be supported. Royal Caribbean clarified in its booking process that gratuities...
Deutsche Bank increased its price target for Kroger to $70 from $68, reflecting a potential 10.7% upside. Kroger announced strategic growth initiatives including a $5 billion customer-value investment and plans to open 110 new stores by 2029. The com...
Crown Castle is set to report its Q3 2026 earnings with Wall Street expecting a 5.9% revenue decline to about $1.01 billion, mainly due to drops in site rental and services revenue. However, some forecasts predict a 7.1% rise in earnings per share to...
PypeServer has released Cloud+ version 3.0, enabling HVAC contractors to manage both ductwork and piping fabrication on a single platform. This update allows seamless tracking from design through installation, integrating with existing design softwar...
Kevel secured $52 million in its largest funding round to date, boosting its AI-powered infrastructure for commerce media networks. The capital will accelerate product innovation, transparent AI decisioning, and global expansion, helping retailers an...
